Deep Track Capital, LP 4 D Molecular Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 4,096,452 shares of FDMT stock, worth $31.1 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
4,096,452
Previous 4,061,401
0.86%
Holding current value
$31.1 Million
Previous $85.2 Million
48.06%
% of portfolio
1.63%
Previous 2.8%
Shares
11 transactions
Others Institutions Holding FDMT
# of Institutions
144Shares Held
57.7MCall Options Held
137KPut Options Held
111K-
Bvf Inc San Francisco, CA7.38MShares$56 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$38.7 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$37.2 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$33.4 Million4.93% of portfolio
-
Goldman Sachs Group Inc New York, NY3.59MShares$27.3 Million0.01% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $246M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...